Nephron Pharmaceuticals Announces Leadership Transition
For best results when printing this announcement, please click on link below: Nephron Pharmaceuticals Announces Leadership Transition Lou Kennedy departs from CEO role; Haywood Miller appointed Interim CEO Company remains focused on executing its transformation strategy and growth priorities while continuing to deliver